The effect of cognitive-behavioral therapy-based intervention on HbA1c of Type II diabetes patients with comorbid metabolic syndrome—a randomised controlled trial

Grifftih University0 sites280 target enrollmentOctober 7, 2021

Overview

No summary available.

Registry

who.int

Start Date

October 7, 2021

End Date

TBD

Last Updated

4 years ago

Study Type

Interventional

Sex

All

Sponsor

Grifftih University

•Key inclusion criteria:
•(1\) The participants will be recruited from the Endocrinology Department of Ningbo First Hospital, Ningbo city, Zhejiang province, China. Recruited participants will be included in this research if they meet the following criteria:
•1\) Diagnosed type 2 diabetes (T2DM) with comorbid metabolic syndrome (MS);
•2\) Age 18\-75 years old;
•3\) Currently does not participate in similar intervention programs;
•4\) Sign an informed consent form, willing to participate in this study, and have good compliance.
•(2\) The specific diagnostic criteria for diabetes refer to the report of the WHO Diabetes Expert Committee, 1999, which is as follows: typical symptoms of diabetes plus
•1\) random blood glucose greater than or equal to 11\.1 mmol/L;
•2\) fasting blood glucose greater than or equal to 7\.0 mmol/L;
•3\) oral glucose tolerance test 2 hours greater than or equal to 11\.1 mmol/L;

•Participants will be excluded from the study if 1\) T1DM; 2\) they are pregnant; 3\) taking medications unrelated to T2DM or MS; 4\) had advanced diabetes complications; 5\) had a severe mental illness, is not able to answer questions and participate in intervention activities; 6\) cannot use the mobile phone.